Workshop
IPTA-SPLIT: Cardiac liver disease

|
Room: TBD
Track: N/A

Description

- Discuss the definition of congestive hepatopathy and cardiac liver disease as whole – including long-term complications and the importance of monitoring
- Review the benefits of liver biopsy in the management of congestive hepatopathy and its impact on the transplant discussion.
- Examine the risk associated with liver biopsy in this patient population and alternative ways to monitor complications of congestive hepatopathy – including the mixed review of liver biopsy pathology benefit

Presentations

Dr. Chaowapong Jarasvaraparn, United States
Congestive hepatopathy: Risks, surveillance and management

Alyssa Kriegermeier, United States
Liver biopsy is key: The importance of a liver biopsy for disease management and long-term predictions

Elizabeth Rand, United States
Liver biopsy is too risky without reward: Alternative ways to monitor congestive hepatopathy and why liver biopsy is not needed

Alyssa Kriegermeier, United States
Pro liver biopsy response

Elizabeth Rand, United States
Con liver biopsy response

Email: info@ipta2025.org
514-874-1717